Cargando…

Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling

Knowledge gaps that limit the development of therapies for polycystic ovary syndrome (PCOS) concern various environmental factors that impact clinical characteristics. Circadian dysrhythmia contributes to glycometabolic and reproductive hallmarks of PCOS. Here, we illustrated the amelioration of Lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shang, Zhai, Junyu, Chu, Weiwei, Geng, Xueying, Wang, Dongshuang, Jiao, Luwei, Lu, Gang, Chan, Wai-Yee, Sun, Kang, Sun, Yun, Chen, Zi-Jiang, Du, Yanzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329655/ https://www.ncbi.nlm.nih.gov/pubmed/37422471 http://dx.doi.org/10.1038/s41522-023-00415-2

Ejemplares similares

Limosilactobacillus reuteri in Health and Disease
por: Abuqwider, Jumana, et al.
Publicado: (2022)

Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications
por: Luo, Zichen, et al.
Publicado: (2023)

Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
por: Piccioni, Andrea, et al.
Publicado: (2021)

Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri
por: Luo, Hao, et al.
Publicado: (2021)

Sleep, circadian dysrhythmia, obesity and diabetes
por: Sridhar, Gumpeny Ramachandra, et al.
Publicado: (2016)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection
por: Dargenio, Costantino, et al.
Publicado: (2021)

Effect of Coix Seed Extracts on Growth and Metabolism of Limosilactobacillus reuteri
por: Yang, Zhoujie, et al.
Publicado: (2022)

Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572
por: Diez-Echave, Patricia, et al.
Publicado: (2021)

Spontaneous Riboflavin-Overproducing Limosilactobacillus reuteri for Biofortification of Fermented Foods
por: Spacova, Irina, et al.
Publicado: (2022)

Limosilactobacillus reuteri inhibits the acid tolerance response in oral bacteria
por: Boisen, Gabriella, et al.
Publicado: (2023)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

The Effect of Limosilactobacillus reuteri on Social Behavior Is Independent of the Adaptive Immune System
por: Dooling, Sean W., et al.
Publicado: (2022)

Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659
por: Sendelius, Malin, et al.
Publicado: (2023)

Probiotic Limosilactobacillus Reuteri (Lactobacillus Reuteri) Extends the Lifespan of Drosophila Melanogaster through Insulin/IGF-1 Signaling
por: Lee, Hye-Yeon, et al.
Publicado: (2023)

Circadian Dysrhythmias, Physiological Aberrations, and the Link to Skin Cancer
por: Gutierrez, Daniel, et al.
Publicado: (2016)

Optimum Fermentation Conditions for Bovine Lactoferricin-Lactoferrampin-Encoding LimosiLactobacillus reuteri and Regulation of Intestinal Inflammation
por: Xie, Weichun, et al.
Publicado: (2023)

Genome Sequence of the Reuterin-Producing Strain Limosilactobacillus reuteri INIA P572
por: Rodríguez-Mínguez, Eva, et al.
Publicado: (2021)

Development of probiotics beverage using cereal enzymatic hydrolysate fermented with Limosilactobacillus reuteri
por: Yang, Zhoujie, et al.
Publicado: (2022)

Lactobacillus (Limosilactobacillus) reuteri: a probiotic candidate to reduce neonatal diarrhea in calves
por: Schwaiger, Karin, et al.
Publicado: (2023)

Draft genome sequence of Limosilactobacillus reuteri, isolated from human breast milk
por: Tyagi, Akanksha, et al.
Publicado: (2023)

Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters
por: Kiezun, Jacek, et al.
Publicado: (2022)

Assessment of the efficacy of a feed additive consisting of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32203 for dogs (NBF LANES)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

Application of Lactobacillus reuteri B1/1 (Limosilactobacillus reuteri) Improves Immunological Profile of the Non-Carcinogenic Porcine-Derived Enterocytes
por: Karaffová, Viera, et al.
Publicado: (2023)

Limosilactobacillus balticus sp. nov., Limosilactobacillus agrestis sp. nov., Limosilactobacillus albertensis sp. nov., Limosilactobacillus rudii sp. nov. and Limosilactobacillus fastidiosus sp. nov., five novel Limosilactobacillus species isolated from the vertebrate gastrointestinal tract, and proposal of six subspecies of Limosilactobacillus reuteri adapted to the gastrointestinal tract of specific vertebrate hosts
por: Li, Fuyong, et al.
Publicado: (2021)

A Phylogenetic View on the Role of Glycerol for Growth Enhancement and Reuterin Formation in Limosilactobacillus reuteri
por: Zhang, Zhihong, et al.
Publicado: (2020)

Distinct B cell subsets in Peyer’s patches convey probiotic effects by Limosilactobacillus reuteri
por: Liu, Hao-Yu, et al.
Publicado: (2021)

Integrative growth physiology and transcriptome profiling of probiotic Limosilactobacillus reuteri KUB-AC5
por: Jatuponwiphat, Theeraphol, et al.
Publicado: (2021)

In Silico Genomic and Metabolic Atlas of Limosilactobacillus reuteri DSM 20016: An Insight into Human Health
por: Smythe, Paisleigh, et al.
Publicado: (2022)

Characterization of adhesion between Limosilactobacillus reuteri and milk phospholipids by density gradient and gene expression
por: Zhang, Lin, et al.
Publicado: (2020)

The probiotic and immunomodulation effects of Limosilactobacillus reuteri RGW1 isolated from calf feces
por: Huang, Kailang, et al.
Publicado: (2023)

Regulatory Influence of Galanin and GALR1/GALR2 Receptors on Inflamed Uterus Contractility in Pigs
por: Jana, Barbara, et al.
Publicado: (2021)

Immunomodulatory Effect of Lactobacillus reuteri (Limosilactobacillus reuteri) and Its Exopolysaccharides Investigated on Epithelial Cell Line IPEC-J2 Challenged with Salmonella Typhimurium
por: Kiššová, Zuzana, et al.
Publicado: (2022)

Reuterin-producing Limosilactobacillus reuteri: Optimization of in situ reuterin production in alginate-based filmogenic solutions
por: Rodrigues, F.J., et al.
Publicado: (2021)

Flow cytometric analysis reveals culture condition dependent variations in phenotypic heterogeneity of Limosilactobacillus reuteri
por: Rao, Nikhil Seshagiri, et al.
Publicado: (2021)

Metagenomic Association Analysis of Gut Symbiont Limosilactobacillus reuteri Without Host-Specific Genome Isolation
por: Park, Sein, et al.
Publicado: (2020)

Limosilactobacillus reuteri Fermented Brown Rice: A Product with Enhanced Bioactive Compounds and Antioxidant Potential
por: Tyagi, Akanksha, et al.
Publicado: (2021)

Investigating Differential Expressed Genes of Limosilactobacillus reuteri LR08 Regulated by Soybean Protein and Peptides
por: Zhu, Shuya, et al.
Publicado: (2022)

Effective encapsulation of reuterin-producing Limosilactobacillus reuteri in alginate beads prepared with different mucilages/gums
por: Rodrigues, F.J., et al.
Publicado: (2022)

Limosilactobacillus reuteri and caffeoylquinic acid synergistically promote adipose browning and ameliorate obesity-associated disorders
por: Liu, Yameng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pt194dc1riifiilslk225ji0eo